Bimatoprost

Product NDC: 50383-908
11-digit product format: 503830908
Labeler code: 50383
Product ID: 50383-908_9e7758d0-19d9-4ee1-86ad-f068a5c98e9d
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Bimatoprost
Dosage form: SOLUTION/ DROPS
Route: OPHTHALMIC
Labeler: Akorn
Application: ANDA203299
Marketing category: ANDA
Marketing start: 2018-11-12
Marketing end: 0000-00-00
Substance: BIMATOPROST
Active strength: 0 mg/mL
Pharmacologic classes: Prostaglandin Analog [EPC], Prostaglandins [CS]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	50383-908		D	Discontinued by firm	2026-08-10
excluded package	package	50383-908	50383-908-02	D	Discontinued by firm	2026-08-10
excluded package	package	50383-908	50383-908-05	D	Discontinued by firm	2026-08-10
excluded package	package	50383-908	50383-908-07	D	Discontinued by firm	2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 60 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50383-908-07	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50383-908-02	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50383-908-05	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50383-908-02	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50383-908-05	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50383-908-07	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50383-908-02	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50383-908-05	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50383-908-07	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50383-908-02	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50383-908-05	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50383-908-07	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50383-908-02	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50383-908-05	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50383-908-07	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50383-908-02	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50383-908-05	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50383-908-07	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50383-908-02	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50383-908-05	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50383-908-07	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50383-908-02	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50383-908-05	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50383-908-07	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50383-908-02	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50383-908-05	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50383-908-07	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50383-908-02	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50383-908-05	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50383-908-07	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50383-908-02	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50383-908-05	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50383-908-07	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50383-908-02	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50383-908-05	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50383-908-07	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	50383-908-02	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	50383-908-05	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	50383-908-07	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	50383-908-02	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	50383-908-05	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	50383-908-07	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	50383-908-02	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	50383-908-05	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	50383-908-07	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A203299-001	BIMATOPROST	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC			2018-11-08

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC	AT	2018-11-08	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A203299-001	BIMATOPROST	0.03%	SOLUTION/DROPS / OPHTHALMIC		2018-11-08	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-07-19 19:46 UTC	2019-07	A203299-001	AT	1	`ea99ee380514…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f71952f0-5c3a-ff37-f1fb-fed3868f6302	Product name	8	20260105
546f403c-5466-48b9-a79e-80b68d2b77d8	Product name	1	20200706
3471d048-4165-432e-a2dc-905eb43247db	Product name	4	20200611

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50383-908-02	2024-01-30	C162847	48780-1	1030e364-ffb9-111a-e063-dadaa90a10e2	These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution for topical ophthalmic use Initial U.S. Approval: 2001
50383-908-05	2024-01-30	C162847	48780-1	1030e364-ffb9-111a-e063-dadaa90a10e2	These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution for topical ophthalmic use Initial U.S. Approval: 2001
50383-908-07	2024-01-30	C162847	48780-1	1030e364-ffb9-111a-e063-dadaa90a10e2	These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution for topical ophthalmic use Initial U.S. Approval: 2001

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50383-908	BIMATOPROST SOLUTION/ DROPS [AKORN]	9	Legacy NDC	20220308_ce5c7f22-ade3-41ea-8dd8-3ec0399d3279.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
QXS94885MZ	BIMATOPROST	155206-00-1	BIMATOPROST

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
50383-908-02	50383090802	1 BOTTLE, DROPPER in 1 CARTON (50383-908-02) > 2.5 mL in 1 BOTTLE, DROPPER	2018-11-12	0000-00-00	No	No	Current
50383-908-05	50383090805	1 BOTTLE, DROPPER in 1 CARTON (50383-908-05) > 5 mL in 1 BOTTLE, DROPPER	2018-11-12	0000-00-00	No	No	Current
50383-908-07	50383090807	1 BOTTLE, DROPPER in 1 CARTON (50383-908-07) > 7.5 mL in 1 BOTTLE, DROPPER	2018-11-12	0000-00-00	No	No	Current